Infection and Immunity, December 2003, p. 6864-6870, Vol. 71, No. 12
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.12.6864-6870.2003
Copyright © 2003, American
Society for
Microbiology. All Rights Reserved.
Characterization of a Protective Monoclonal Antibody Recognizing Staphylococcus aureus MSCRAMM Protein Clumping Factor A
Andrea E. Hall,1 Paul J. Domanski,1 Pratiksha R. Patel,1 John H. Vernachio,1 Peter J. Syribeys,1 Elena L. Gorovits,1 Michael A. Johnson,2 Julia M. Ross,2 Jeff T. Hutchins,1 and Joseph M. Patti1*
Inhibitex,
Inc., Alpharetta,
Georgia,1
Department of Chemical and
Biochemical Engineering, University of Maryland, Baltimore,
Maryland2
Received 6 June 2003/
Returned for modification 21 July 2003/
Accepted 2 September 2003
The
Staphylococcus aureus MSCRAMM (microbial surface
components recognizing adhesive matrix molecules) protein clumping
factor A (ClfA) has been shown to be a critical virulence
factor in several experimental models of infection. This report
describes the generation, characterization, and in vivo evaluation of a
murine monoclonal antibody (MAb) against ClfA. Flow cytometric analysis
revealed that MAb 12-9 recognized ClfA protein expressed by all of the
clinical S. aureus strains obtained from a variety of
sources. In assays measuring whole-cell S. aureus
binding to human fibrinogen, MAb 12-9 inhibited S.
aureus binding by over 90% and displaced up to
35% of the previously adherent S. aureus
bacteria. Furthermore, a single infusion of MAb 12-9 was protective
against an intravenous challenge with a methicillin-resistant strain of
S. aureus in a murine sepsis model (P
< 0.0001). These data suggest that anti-ClfA MAb 12-9 should be
further investigated as a novel immunotherapy for the treatment and
prevention of life-threatening S. aureus
infections.
* Corresponding
author. Mailing address: Inhibitex, Inc., 1165 Sanctuary Parkway, Suite
400, Alpharetta, GA 30004. Phone: (678) 746-1144. Fax: (678) 336-1214.
E-mail:
jpatti{at}inhibitex.com.
Editor:
F. C. Fang
Infection and Immunity, December 2003, p. 6864-6870, Vol. 71, No. 12
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.12.6864-6870.2003
Copyright © 2003, American
Society for
Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Bekeredjian-Ding, I., Inamura, S., Giese, T., Moll, H., Endres, S., Sing, A., Zahringer, U., Hartmann, G.
(2007). Staphylococcus aureus Protein A Triggers T Cell-Independent B Cell Proliferation by Sensitizing B Cells for TLR2 Ligands. J. Immunol.
178: 2803-2812
[Abstract]
[Full Text]
-
Procopio Evagrio George, N., Wei, Q., Kyun Shin, P., Konstantopoulos, K., Ross, J. M.
(2006). Staphylococcus aureus Adhesion via Spa, ClfA, and SdrCDE to Immobilized Platelets Demonstrates Shear-Dependent Behavior. Arterioscler. Thromb. Vasc. Bio.
26: 2394-2400
[Abstract]
[Full Text]
-
Weems, J. J. Jr., Steinberg, J. P., Filler, S., Baddley, J. W., Corey, G. R., Sampathkumar, P., Winston, L., John, J. F., Kubin, C. J., Talwani, R., Moore, T., Patti, J. M., Hetherington, S., Texter, M., Wenzel, E., Kelley, V. A., Fowler, V. G. Jr.
(2006). Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of Staphylococcus aureus Bacteremia.. Antimicrob. Agents Chemother.
50: 2751-2755
[Abstract]
[Full Text]
-
Pourmand, M. R., Clarke, S. R., Schuman, R. F., Mond, J. J., Foster, S. J.
(2006). Identification of Antigenic Components of Staphylococcus epidermidis Expressed during Human Infection.. Infect. Immun.
74: 4644-4654
[Abstract]
[Full Text]
-
Kuklin, N. A., Clark, D. J., Secore, S., Cook, J., Cope, L. D., McNeely, T., Noble, L., Brown, M. J., Zorman, J. K., Wang, X. M., Pancari, G., Fan, H., Isett, K., Burgess, B., Bryan, J., Brownlow, M., George, H., Meinz, M., Liddell, M. E., Kelly, R., Schultz, L., Montgomery, D., Onishi, J., Losada, M., Martin, M., Ebert, T., Tan, C. Y., Schofield, T. L., Nagy, E., Meineke, A., Joyce, J. G., Kurtz, M. B., Caulfield, M. J., Jansen, K. U., McClements, W., Anderson, A. S.
(2006). A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis Model. Infect. Immun.
74: 2215-2223
[Abstract]
[Full Text]
-
Maira-Litran, T., Kropec, A., Goldmann, D. A., Pier, G. B.
(2005). Comparative Opsonic and Protective Activities of Staphylococcus aureus Conjugate Vaccines Containing Native or Deacetylated Staphylococcal Poly-N-Acetyl-{beta}-(1-6)-Glucosamine. Infect. Immun.
73: 6752-6762
[Abstract]
[Full Text]
-
Domanski, P. J., Patel, P. R., Bayer, A. S., Zhang, L., Hall, A. E., Syribeys, P. J., Gorovits, E. L., Bryant, D., Vernachio, J. H., Hutchins, J. T., Patti, J. M.
(2005). Characterization of a Humanized Monoclonal Antibody Recognizing Clumping Factor A Expressed by Staphylococcus aureus. Infect. Immun.
73: 5229-5232
[Abstract]
[Full Text]
-
Goerke, C., Fluckiger, U., Steinhuber, A., Bisanzio, V., Ulrich, M., Bischoff, M., Patti, J. M., Wolz, C.
(2005). Role of Staphylococcus aureus Global Regulators sae and {sigma}B in Virulence Gene Expression during Device-Related Infection. Infect. Immun.
73: 3415-3421
[Abstract]
[Full Text]
-
Dryla, A., Prustomersky, S., Gelbmann, D., Hanner, M., Bettinger, E., Kocsis, B., Kustos, T., Henics, T., Meinke, A., Nagy, E.
(2005). Comparison of Antibody Repertoires against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients. CVI
12: 387-398
[Abstract]
[Full Text]
-
Liu, Y., Ames, B., Gorovits, E., Prater, B. D., Syribeys, P., Vernachio, J. H., Patti, J. M.
(2004). SdrX, a Serine-Aspartate Repeat Protein Expressed by Staphylococcus capitis with Collagen VI Binding Activity. Infect. Immun.
72: 6237-6244
[Abstract]
[Full Text]
-
Sillanpaa, J., Xu, Y., Nallapareddy, S. R., Murray, B. E., Hook, M.
(2004). A family of putative MSCRAMMs from Enterococcus faecalis. Microbiology
150: 2069-2078
[Abstract]
[Full Text]
Copyright © 2003 by the American Society for Microbiology. All rights reserved.